fda compounding glp-1 warning letters september 2025 30 telehealth companies received U.S. Food and Drug Administration for falsely marketing products online. said these companies claimed that their compounded products are similar to generic FDA-approved products U.S. FDA | FDA is
Description
With 13 states offering coverage, its already a $3.9 billion cost
Explore the evidence linking tirzepatide to leg discomfort, understand potential mechanisms, and discover practical management strategies

Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide weight-control medications to its members.

It should be noted that while GLP-1 agonists positively impact metabolism upstream of the liver, this may not subsequently improve the fibrotic liver injury within the tested treatment duration